Abstract
Introduction
Fasciola hepatica (liver fluke) is a parasite of great socioeconomic importance. A number of fluke isolates have been identified; however, to date the differences between the immunomodulatory properties of different parasite isolates have not been sufficiently investigated. The aim of this study was to explore differences between the immunomodulatory properties of two F. hepatica isolates using unmaturated bovine macrophages.
Material and Methods
A cell line of bovine macrophages was stimulated with excretory/secretory products released by adult flukes from either a laboratory (Fh-WeyES) or wild (Fh-WildES) strain and subsequently subjected to microarray and ELISA analyses. Results: Both Fh-WeyES and Fh-WildES dampened the release of interleukin-10 by bovine macrophages, but only Fh-WildES dampened the release of proinflammatory tumour necrosis factor-α. Microarray analysis revealed that Fh-WildES down- and upregulated 90 and 18 genes, respectively, when compared to Fh-WeyES.
Conclusion
The results indicated different impacts of the isolates on macrophages. A number of researchers use flukes obtained from local slaughterhouses for experiments. Our findings may explain some discrepancies between published results arising from parasite strain choice. The findings indicate that consideration should be given to the use of different strains, and open new and currently unexplored avenues in parasitology for controlling the parasite.
Keywords: Fasciola hepatica, macrophages, gene expression, immunoregulation, immune modulation
Introduction
Fasciola hepatica (liver fluke) is a parasite of great socioeconomic importance, with a worldwide distribution. The parasite infects a variety of mammalian hosts and is responsible for significant losses in animal production estimated at over US$ 3.2 billion per year (21). Adult parasites settle in the bile ducts where they mature and cause long-lasting infections inflicting liver damage.
F. hepatica, like other helminths, has developed sophisticated mechanisms to trick, evade, and shift the host immune response. The fluke inhibits dendritic cells’ maturation, induces the M2 phenotype in macrophages, and promotes IL-10 secretion. Many of these powerful immunomodulators are antigens actively released by the parasite as components of F. hepatica excretory/secretory products (Fh-ES). Despite reports of intraspecies differences among F. hepatica isolates, immunomodulatory properties have not been as thoroughly investigated as drug resistance (8).
We previously investigated the influence of Fh-ES from a laboratory Weybridge (Fh-WeyES) isolate and a wild (Fh-WildES) isolate strain on LPS-activated macrophages. Both isolates were able to dampen TNF-α release, whereas only the wild isolate dampened release of IL-10 from LPS-activated macrophages (2). For further characterisation of the immunomodulatory differences between isolates, we stimulated a bovine monocyte/macrophage (BOMA) cell line with Fh-ES obtained from a commercially available Weybridge isolate of F. hepatica and Fh-ES from a wild isolate. Bovine macrophages were used since ruminants, the most economically important definitive hosts, are of special interest for drug and vaccine development. The paradigm of the immune response following exposure to the parasite is a shift towards a regulatory phenotype with diminishing proinflammatory effects. Despite human or mouse models usually being first choice in hepatic inflammation research, bovine cells have also shown increased release of IL-10 during chronic liver fluke infection (11). IL-12 and TNF-α are typical proinflammatory cytokines released by bovine cells upon Mycoplasma bovis stimulation (17) and greater attention to their regulation during fasciolosis is required. To uncover the different effects Fh-WeyES and Fh-WildES have on macrophages, analyses of macrophage transcriptomes and levels of released IL-10, IL-12, and TNF-α were undertaken. Microarray analysis of gene expression is the first step to comprehending the intracellular pathways of signalling. Analyses of gene networks are complicated and computational technology is still being developed; however, the identified genes may be classified as modulators of the immune response, and the data may be very helpful in future meta-analyses. Transcriptome analyses combined with measurements of cytokine levels were applied here to shed light on the interactions between bovine macrophages and F. hepatica.
Material and Methods
Fasciola hepatica excretory–secretory (Fh-ES) products collection. The CVL Weybridge isolate has been maintained in our laboratory since 2003 through experimental infections of sheep and Galba truncatula snails. Sheep were euthanised to collect adult flukes of the Weybridge isolate. Wild isolate flukes were collected from bison which were culled at Bialowieża National Park (Poland) in order to maintain the population in good condition. Fh-ES were collected as described previously (1). Briefly, adult flukes were collected and rinsed in PBS and then incubated (2 h, 37°C). Media containing residues of host proteins and bile were discarded. Flukes were then incubated (2 h, 37°C, 5% CO2) in Roswell Park Memorial Institute-1640 medium (supplemented with 100 U/mL of penicillin and 0.1 mg/mL of streptomycin) for 24 h, with 4-hourly changes. Six batches of collected media (containing Fh-WeyES or Fh-WildES) were combined, spun (4,500 × g, 20 min, 4°C), and concentrated using a Centricon device with a 3 kDa cut-off (EMD Millipore, Ireland). The samples containing Fh-WeyES or Fh-WildES were titrated and stored at −80°C. Before cell stimulation, the samples were passed through a 0.2 μm filter. The protein concentrations of the samples were determined by Bradford assay.
BOMA cell stimulation with Fasciola hepatica excretory – secretory (Fh-ES) products. The bovine monocyte/macrophage cell line was propagated as previously described (3). Briefly, cells were cultured in Dulbecco’s modified Eagle’s medium (with 5% FCS, 2 mM of glutamine, 100 units/mL of penicillin, 100 μg/mL of streptomycin); during the experiment the cells were seeded into 24-well dishes at a concentration of 6.4 × 105 cells/mL and stimulated in quadruplicate with Fh-WeyES or Fh-WildES at a final concentration of 10 μg/mL for 24 h, scraped and centrifuged. Unstimulated cells were treated as controls. Cells and media were stored separately at −70°C and −20°C, respectively.
Microarray experiments. Total RNA was isolated from both stimulated and control cells using a total RNA isolation kit (A&A Biotechnology, Poland). The genomic DNA residues were removed using DNAseI (Thermo Scientific, Lithuania) according to the manufacturer`s protocol, followed by phenol-chloroform extraction. The concentration of the RNA was determined spectrophotometrically. RNA from control and stimulated cells was labelled using Cy3 and Cy5, respectively, using a Quick Amp labelling kit (Agilent Technologies, USA). The further steps of the microarray experiment were performed according to the manufacturer`s instructions (Agilent Technologies).
Data analyses. The statistical analysis was performed using GeneSpring software (Agilent Technologies). Eight microarrays were analysed together. A baseline was created using the median of all samples, followed by filtering on flags to identify mRNAs that changed expression after Fh-WildES stimulation (compared to cells stimulated with Fh-WeyES – the laboratory strain was adopted as the control). Moderated t-tests (P < 0.05) were applied and Westfall–Young permutative correction was undertaken. The results were filtered, and probes indicating expression changes over two-fold were used for further analyses.
The involvement of the identified genes in various biological processes was determined using PANTHER (21) and the DAVID classification system (16). Other genes that may be involved in the immune response were added by examination of gene lists that exhibited changed expression and that were not classified by PANTHER or DAVID as participants in the immune response.
ELISA. Collected media were tested for the presence of TNF-α (Bovine TNF-α DuoSet ELISA, R&D Systems, USA), IL-10 (BioTSZ, USA), and IL-12 (BioTSZ, USA). Statistical analyses were performed using Student’s t-test with STATISTICA 10 software.
Combining genomic data with release of IL-10 and TNF-α. To assess whether transcriptomic changes affected cytokine expression, computational analyses were performed. Using GeneMANIA (22), potential functional interactions and coexpression between genes were identified. Due to the lack of appropriate databases for cattle, mouse, rat, or human databases were used.
Results
Fh-ES from reference and wild isolates of F. hepatica induce different gene expression profiles. After stimulation of cells with Fh-WildES, 30 probes identified mRNAs as upregulated and 131 as downregulated compared to gene expression after Fh-WeyES stimulation (full list in supplement 1). These probes identified 18 and 90 mRNAs, respectively, which were deemed to be involved in various biological processes (Fig. 1).
Fig. 1.

Genes involved in biological processes identified by PANTHER
Upon further literature review 3 upregulated and 22 downregulated mRNAs were identified as genes involved in immune responses (Table 1). The genes involved in immune responses were comprehensively analysed, and their potential functions during fasciolosis are hypothesised. Each one’s influence on the immune response (associated with their expression change) during an infection was hypothesised and classed as an „increase”, „decrease”, „unknown” or „complicated” (Table 1). Although these effects are only hypotheses, they indicate the potential influence and outcomes of Fh-ES from both strains on the immune system.
Table 1.
Genes (involved in immune response) with changed expression level after macrophage stimulation with Fh-WildES (compared to Fh-WeyES
| Gene downregulated in macrophages stimulated with Fh-WildES compared to macrophages stimulated with Fh-WeyES | GenBank No. | Predicted influence on immune response after expression change |
|---|---|---|
| C-type lectin domain family 12 member A (CLEC12A) | NM_001105345 | Complicated |
| Oligoadenylate synthetase 2 (OAS2) | NM_001024557 | Decrease |
| C-type lectin domain family 4 member G (CLEC4G) | NM_001205606 | Unknown |
| GTPase, IMAP family member 1 (GIMAP1) | NM_001083677 | Decrease |
| Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, delta NFKBID) | NM_001193019 | Increase |
| Cell division cycle 25A (CDC25A)TNF-α | NM_001101100 | Decrease |
| Chemokine (C-X-C motif) ligand 2 (CXCL2) | NM_001048165 | Decrease |
| Cytokine receptor-like factor 2 (TSLPR) TNF-α, IL-10 | XM_010800619 | Decrease |
| Glycerol-3-phosphate acyltransferase, mitochondrial (GPAM) TNF-α, IL-10 | NM_001012282 | Decrease |
| Coronin, actin binding protein 1A (CORO1A) | NM_174521 | Decrease |
| Immunoglobulin superfamily member 8 (IGSF8) | NM_001082439 | Complicated |
| Interferon regulatory factor 6 (IRF6) | NM_001076934 | Increase |
| Inteferon omega 1 ( IFN-ω1) | NM_174351 | Decrease |
| Killer cell lectin-like receptor B1 (KLRB1) | NM_001206636 | Complicated |
| Mitogen-activated protein kinase 13 (p38δ) | NM_001014947 | Decrease |
| Thymus-specific serine protease (TSSP) IL-10 | BC148914 | Decrease |
| Regulator of G-protein signalling 13 (RGS13) | NM_001080232 | Increase |
| Transcription factor EC (TFEC) TNF-α, IL-10 | NM_001083739 | Complicated |
| T-cell receptor alpha chain V region (TRAδ) | JX101718 | Decrease |
| CD63 molecule(CD63) | XM_002699657 | Decrease |
| Complement component 3a receptor 1 (C3AR1)TNF-α, IL-10 | NM_001083752 | Decrease |
| Complement factor H (CFH) | NM_001033936 | Increase |
| Gene upregulated in macrophages stimulated with Fh-WildES compared to macrophages stimulated with Fh-WeyES | ||
| SAM and SH3 domain-containing 1 (SASH1) | XM_588302 | Increase |
| Cathelicidin 2 (CATHL2) | NM_174826 | Increase |
| Oncostatin M (OSM) | NM_175713 | Complicated |
Superscript shows genes which exhibited altered expression levels upon stimulation and directly interact with the cytokine TNF-α or IL-10
ES from laboratory and wild isolates of F. hepatica decreased IL-10 secretion, whereas only ES from the wild isolate decreased TNF-α secretion. After stimulation of BOMA cells with Fh-WildES and Fh-WeyES, IL-10 levels decreased by 38% and 41%, respectively (Fig. 2A). Stimulation with Fh-WildES resulted in a 19% reduction of TNF-α, whereas no effect was observed from Fh-WeyES stimulation (Fig. 2B). The basal level of IL-12 secreted by BOMA cells was below the detection threshold, and stimulation with Fh-WildES or Fh-WeyES did not induce release of the cytokine (data not shown).
Fig. 2.

Concentration of IL-10 (A) and TNF-α (B) after stimulation of bovine macrophages (BOMA) with Fh-WeyES or Fh-WildES. Each sample consisted of four replications. Mean and SEM are shown
* – significant difference compared to control cells (P < 0.05)
Genes with altered expression show association with TNF-α and IL-10 levels. Upon analysis of genes engaged in immune responses, six gene products showed interactions with TNF-α or IL-10, whereas two gene products showed the same expression localisation as the cytokines (Fig. 3). Moreover, a number of interactions were detected among the gene products engaged in immune responses (Fig. 3), as well as with related genes (Fig. 4).
Fig. 3.

Predicted interactions between TNF-α, IL-10, and products of genes with altered expression levels. Potential functional interactions (green) and joint expression location (red) were identified. If two genes were identified as having both functional and colocalised expression they were plotted with yellow
Fig. 4.

Predicted functional interactions between genes engaged in immune responses and related genes. Green – membrane associated genes, violet – complement associated genes, blue – cytokines and chemokines, yellow – other. Outer genes (blue with dark outline) are related genes identified by GeneMania
When analysing all genes with altered expression with TNF-α and IL-10, TNF-α was revealed to interact with ACTA1 (actin, alpha 1, skeletal muscle), CDH13 (cadherin 13), and PIWIL2 (piwi-like RNA-mediated gene silencing 2), and IL-10 with CNIH3 (cornichon family AMPA receptor auxiliary protein 3). All identified interactions are shown in supplement 2.
Discussion
Fh-WildES up- and downregulated 18 and 90 mRNAs, respectively, compared to Fh-WeyES (the F. hepatica laboratory strain considered as the control); these are comparable numbers to the 27 upregulated and 30 downregulated genes observed when LPS-activated BOMA cells were stimulated with Fh -WeyES and Fh-WildES (2). As it has been discussed previously (2), comparisons with other transcriptomic analyses of F. hepatica interactions with host cells are limited, as previous analyses only investigated the effects from one fluke isolate (12). However, similar findings come from analysis of the response to another helminth, Trichuris muris where two isolates induced differences in gene expression detected by 268 probes (7). Nevertheless, a direct comparison with these results is limited as we worked on a single cell population, while the T. muris experiments were performed on gut tissue which is comprised of a number of cell populations. A similar situation occurs when comparing isolates of protozoan parasites: Toxoplasma gondii and Trypanosoma brucei isolates have been shown to dysregulate 310 to 920 mRNAs (15, 23) in peritoneal cells (15) or splenocytes (23). Despite differences in study methodology, these findings when compared provide some clarity on the number of genes that may be dysregulated by distinct isolates of particular parasites.
Detailed microarray analysis showed that there were significant differences in gene expression levels in macrophages in response to Fh-WildES and Fh-WeyES, including to NF-κβ associated genes. Transcription factor NF-κβ stays inactive when coupled to its inhibitor, – IκB. Upon activation, IκB is phosphorylated, ubiquitinated, and targeted for proteasomal degradation, while free NF-κβ translocates into the nucleus where it modulates gene expression, orchestrating the immune response. Although F. hepatica tegumental antigens have been shown to decrease NF-κβ activity, these findings did not provide information about the strain of fluke (14). Our findings show that Fh-ES may significantly affect NF-κβ pathways. Fh-WildES boosts the immune response via NFKBID and IRF6 downregulation and SASH1 upregulation which may lead to improvement of NF-κβ signal transduction and induction of inflammation (6). Alternatively, CDC25 and CXCL2 were dampened by Fh-WildES, which skews the immune response towards suppression. While the overall effect on NF-κβ signalling is intricate, it indicates that different pathways are affected by the two isolates and in macrophages the induction of particular suppressive pathways may be compensated for by upregulation of certain proinflammatory pathways, e.g. through the dampened expression of other signalling-engaged genes. In regard to genes associated with other signalling pathways, Fh-WildES induced p38δ and downregulated GIMAP1, which clearly skews the immune response towards a Threg/Th2 phenotype through dampening of TNF-α release (26), whereas RGS13 downregulation by Fh-WildES favours the induction of inflammation. The effects of TFEC downregulation following Fh-WildES exposure are complicated since lower expression may result in impaired development of alternatively activated macrophages (30) which show a suppressive effect, but may, however, play a role in parasite expulsion. The results suggest that different pathways are affected to different degrees by various isolates. Different parasite isolates may influence different routes to achieve similar end results in immune regulation, while the degree to which different parasite isolates can depress certain protective immune responses, or induce non-protective/helpful immune responses also appears to differ.
Whereas dysregulation of genes involved in intracellular signalling pathways shows that both strains may skew the immune response towards either inflammation or suppression, changes to the expression of genes encoding membrane-associated and other intracellular proteins favour the hypothesis that the wild isolate induces stronger immunosuppression than the laboratory isolate. Fh-WildES diminished CD63, TSLPR, and TRAδ expression, which leads to impairment of mast cell degranulation (18) and antigen presentation (25). T cell functioning is also abrogated by TSSP, GPAM, and CORO1A downregulation, resulting in depleted T cell numbers, abrogation of receptor repertoire, and impaired IFN-γ release (5, 28). Similar effects may come from the dysregulation of the intercellular proteins TSSP and GPAM which regulate T cell function. The possibility of a stronger Fh-WildES suppressive effect also seems to be corroborated by OAS2 downregulation; its role in parasitic infection has not been confirmed, nevertheless its antiviral properties support the hypothesis that decreased expression would favour immune response inhibition. Other proteins associated with membranes (IGSF8, CLEC4G, KLRB1, and CLEC12A) were also expressed distinctly; however, their influence on the immune response against fluke is unresolved. Nevertheless, especially those containing C-type lectin domains (CLEC4G, KLRB1, and CLEC12A) may recognise F. hepatica antigens and affect the immune response (27). A complicated situation occurs also in regard to downregulation of OSM belonging to the IL-6 family. Downregulation of another cytokine, IFN-ω1, by Fh-WildES is likely to dampen the immune response. Fh-WildES also dampened expression of CFH and C3AR1, which may induce or suppress complement action by allowing its activation or reducing C3a signal transduction, respectively. Another secreted factor with altered expression was CATHL2, an antimicrobial peptide. Its immature form may restrain inflammation by inhibiting host cathepsin L engaged in elastinolytic and collagenolytic activities (29). This is significant not only in regard to the anti-inflammatory effects, but also due to the abundance of cysteine proteases among antigens released by F. hepatica (24). The cysteine proteases of F. hepatica can cleave TLR3 and CD4, which inhibits the release of pro-inflammatory factors or affects T cell function and has also been shown to cleave host immunoglobulins (24). If CATHL2 inhibits liver fluke cysteine proteases, it may be an important as yet unexplored pathway of defence against fluke infection.
Computational analysis showed that six genes may have functional interactions with TNF-α and IL-10, influencing their expression levels and providing an insight into the mechanisms of change of cytokine levels. Fh-ES from both isolates dampened the release of immunosuppressive IL-10. However, a different expression pattern was observed when LPS-maturated macrophages were stimulated with Fh-ES from both isolates, with IL-10 levels inhibited more upon exposure to Fh-WildES (2). This difference may result from the different state of the macrophages (LPS-maturated or naive) which express different sets of receptors and show distinct responses to stimuli. Other findings show potentiated release of IL-10 during infection by peripheral blood mononuclear cells (11). However, macrophages alone from infected animals showed reduced ability to release IL-10; moreover, the reduction was most pronounced in the animals harbouring more flukes (13). This data may corroborate the hypothesis raised previously (2) that increased release of IL-10 by peripheral blood mononuclear cells is caused by cells other than monocytes/macrophages. Regarding TNF-α, Fh-WildES exposure led to diminished TNF-α release. The ability of Fh-ES to dampen TNF-α release is in concordance with our previous findings (2) and with the ability of fluke tegumental antigens to impair TNF-α release (14). It should be remembered that here cells were stimulated with Fh-ES from two isolates of one parasite species, which show a high degree of similarity, and only slight differences in ES composition or sequence variability among immunomodulatory proteins are likely to occur. Thus, while differences in the levels of the released cytokines were not large, nevertheless they did exist. The more potent immunosuppressive potential of the wild isolate may result from the greater genetic diversity of the population from which the Fh-ES was obtained, with the strain also under higher selection pressure in the field than the laboratory isolate which has been maintained in the laboratory for several generations. As such, the Fh-ES of the wild isolate would be expected to contain a more diverse milieu of proteins, possibly explaining its more profound effects. Regarding Fh-WeyES, it is expected to be produced from extremely genetically similar flukes, so it is expected that protein sequences and levels would be relatively consistent, while for Fh-WildES, greater protein expression variability would be expected.
Highlighting the various immunomodulatory abilities of liver fluke isolates has practical implications. Nowadays, parasites are not only considered foes but also future remedies for increasingly common autoimmune diseases and allergies. F. hepatica exposure has been shown to be promising in the mitigation of autoimmune and allergic diseases (9, 19). Our findings indicate that research should be performed with fully-typed laboratory isolates, or that when using flukes collected from abattoirs or the environment, it is worth preserving isolates that show abilities to mitigate symptoms of allergies or autoimmune diseases for future cultivation. This will allow future detailed insights and characterisation, which will be a boon when the results are promising and worthy of further exploration. It is also possible that some discrepancies in the literature may be attributable to differences between various isolates of the flukes investigated, e.g. differences in susceptibility to bacterial coinfections (4, 10).
Summing up, the findings show that distinct isolates of F. hepatica show different immunomodulatory potentials and suggest stronger immunosuppressive abilities for the wild isolate. This may shed some light on some discrepant literature data and underlines the importance of providing information on the source of F. hepatica isolates in publications. We believe that further exploration of intraspecies variability in F. hepatica immunomodulatory abilities will provide a deeper understanding of the interplay between the host and the liver fluke as well as lead to those isolates being identified, which exhibit the most suitable abilities to mitigate allergies and autoimmune diseases.
Acknowledgements
We are grateful to the Scientific Council of Białowieża National Park which gave us permission to collect biological material from the bisons.
Footnotes
Conflict of Interest
Conflict of Interests Statement: The authors declare that there is no conflict of interests regarding the publication of this article.
Financial Disclosure Statement: This research was supported by a grant from the Polish National Science Centre (project no. N N304 156340).
Animal Rights Statement: All experiments with animals followed institutional ethical guidelines and were approved by the Third Local Ethical Committee of Warsaw University of Life Sciences – SGGW (permission no. 82/2010).
Availability of Data and Material: The datasets analysed during the current study are available from the corresponding author on reasonable request. The raw data of the experiment were deposited in GEO (no. GSE95019).
Supplementary Material.
References
- 1.Bąska P., Norbury L.J., Wiśniewski M., Januszkiewicz K., Wędrychowicz H.. Excretory/secretory products of Fasciola hepatica but not recombinant phosphoglycerate kinase induce death of human hepatocyte cells. Acta Parasitol. 2013;58:215–217. doi: 10.2478/s11686-013-0126-x. [DOI] [PubMed] [Google Scholar]
- 2.Bąska P., Norbury L.J., Zawistowska-Deniziak A., Wiśniewski M., Januszkiewicz K.. Excretory/secretory products from two Fasciola hepatica isolates induce different transcriptional changes and IL-10 release in LPS-activated bovine “BOMA” macrophages. Parasitol Res. 2017;116:2775–2782. doi: 10.1007/s00436-017-5588-6. [DOI] [PubMed] [Google Scholar]
- 3.Bąska P., Zawistowska-Deniziak A., Zdziarska A.M., Wasyl K., Wiśniewski M., Cywińska A., Klockiewicz M., Januszkiewicz K., Wędrychowicz H.. Fasciola hepatica - the pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke. Acta Parasitol. 2013;58:453–462. doi: 10.2478/s11686-013-0163-5. [DOI] [PubMed] [Google Scholar]
- 4.Brady M.T., O’Neill S.M., Dalton J.P., Mills K.H.. Fasciola hepatica suppresses a protective Th1 response against Bordetella pertussis. Infect Immun. 1999;67:5372–5378. doi: 10.1128/iai.67.10.5372-5378.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Collison L.W., Murphy E.J., Jolly C.A.. Glycerol-3-phosphate acyltransferase-1 regulates murine T-lymphocyte proliferation and cytokine production. Am J Physiol Cell Physiol. 2008;295:1543–1549. doi: 10.1152/ajpcell.00371.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dauphinee S.M., Clayton A., Hussainkhel A., Yang C., Park Y.J., Fuller M.E., Blonder J., Veenstra T.D., Karsan A.. SASH1 is a scaffold molecule in endothelial TLR4 signaling. J Immunol. 2013;191:892–901. doi: 10.4049/jimmunol.1200583. [DOI] [PubMed] [Google Scholar]
- 7.D’Elia R., DeSchoolmeester M.L., Zeef L.A., Wright S.H., Pemberton A.D., Else K.J.. Expulsion of Trichuris muris is associated with increased expression of angiogenin 4 in the gut and increased acidity of mucins within the goblet cell. BMC Genomics. 2009;10:492. doi: 10.1186/1471-2164-10-492. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fairweather I.. Liver fluke isolates: a question of provenance. Vet Parasitol. 2011;176:1–8. doi: 10.1016/j.vetpar.2010.12.011. [DOI] [PubMed] [Google Scholar]
- 9.Finlay C.M., Stefanska A.M., Coleman M.M., Jahns H., Cassidy J.P., McLoughlin R.M., Mills K.H.G.. Secreted products of Fasciola hepatica inhibit the induction of T cell responses that mediate allergy. Parasite Immunol. 2017;39 doi: 10.1111/pim.12460. [DOI] [PubMed] [Google Scholar]
- 10.Flynn R.J., Mulcahy G., Welsh M., Cassidy J.P., Corbett D., Milligan C., Andersen P., Strain S., McNair J.. Co-infection of cattle with Fasciola hepatica and Mycobacterium bovisimmunological consequences. Transbound Emerg Dis. 2009;56:269–274. doi: 10.1111/j.1865-1682.2009.01075.x. [DOI] [PubMed] [Google Scholar]
- 11.Flynn R.J., Mulcahy G.. The roles of IL-10 and TGF-beta in controlling IL-4 and IFN-gamma production during experimental Fasciola hepatica infection. Int J Parasitol. 2008;38:1673–1680. doi: 10.1016/j.ijpara.2008.05.008. [DOI] [PubMed] [Google Scholar]
- 12.Fu Y., Chryssafidis A.L., Browne J.A., O’Sullivan J., McGettigan P.A., Mulcahy G.. Transcriptomic study on ovine immune responses to Fasciola hepatica infection. PLoS Negl Trop Dis. 2016;10:e0005015. doi: 10.1371/journal.pntd.0005015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Haçariz O., Sayers G., Flynn R.J., Lejeune A., Mulcahy G.. IL-10 and TGF-beta1 are associated with variations in fluke burdens following experimental fasciolosis in sheep. Parasite Immunol. 2009;31:613–622. doi: 10.1111/j.1365-3024.2009.01135.x. [DOI] [PubMed] [Google Scholar]
- 14.Hamilton C.M., Dowling D.J., Loscher C.E., Morphew R.M., Brophy P.M., O’Neill S.M.. The Fasciola hepatica tegumental antigen suppresses dendritic cell maturation and function. Infect Immun. 2009;77:2488–2498. doi: 10.1128/IAI.00919-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hill R.D., Gouffon J.S., Saxton A.M., Su C.. Differential gene expression in mice infected with distinct Toxoplasma strains. Infect Immun. 2012;80:968–974. doi: 10.1128/IAI.05421-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Huang da W., Sherman B.T., Lempicki R.A.. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1–13. doi: 10.1093/nar/gkn923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jimbo S., Suleman M., Maina T., Prysliak T., Mulongo M., Perez-Casal J.. Effect of Mycoplasma bovis on bovine neutrophils. Vet Immunol Immunopathol. 2017;188:27–33. doi: 10.1016/j.vetimm.2017.04.011. [DOI] [PubMed] [Google Scholar]
- 18.Kraft S., Fleming T., Billingsley J.M., Lin S.Y., Jouvin M.H., Storz P., Kinet J.P.. Anti-CD63 antibodies suppress IgE-dependent allergic reactions in vitro and in vivo. J Exp Med. 2005;201:385–396. doi: 10.1084/jem.20042085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Lund M.E., O’Brien B.A., Hutchinson A.T., Robinson M.W., Simpson A.M., Dalton J.P., Donnelly S.. Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse. PLoS One. 2014;9:e86289. doi: 10.1371/journal.pone.0086289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.McNulty S.N., Tort J.F., Rinaldi G., Fischer K., Rosa B.A., Smircich P., Fontenla S., Choi Y.J., Tyagi R., Hallsworth-Pepin K., Mann V.H., Kammili L., Latham P.S., Dell’Oca N., Dominguez F., Carmona C., Fischer P.U., Brindley P.J., Mitreva M.. Genomes of Fasciola hepatica from the Americas reveal colonization with Neorickettsia Endobacteria related to the agents of Potomac Horse and Human Sennetsu Fevers. PLoS Genet. 2017;6:13. doi: 10.1371/journal.pgen.1006537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Mi H., Poudel S., Muruganujan A., Casagrande J.T., Thomas P.D.. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res. 2016;44:336–342. doi: 10.1093/nar/gkv1194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Montojo J., Zuberi K., Rodriguez H., Bader G.D., Morris Q.. GeneMANIA: Fast gene network construction and function prediction for Cytoscape. eCollection 2014. F1000Res. 2014;3(1):153. doi: 10.12688/f1000research.4572.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Morrison L.J., McLellan S., Sweeney L., Chan C.N., MacLeod A., Tait A., Turner C.M.. Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection. Infect Immun. 2010;78:1096–1108. doi: 10.1128/IAI.00943-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Norbury L.J., Beckham S., Pike R.N., Grams R., Spithill T.W., Fecondo J.V., Smooker P.M.. Adult and juvenile Fasciola cathepsin L proteases: different enzymes for different roles. Biochimie. 2011;93:604–611. doi: 10.1016/j.biochi.2010.12.004. [DOI] [PubMed] [Google Scholar]
- 25.Park J.H., Jeong D.Y., Peyrin-Biroulet L., Eisenhut M., Shin J.I.. Insight into the role of TSLP in inflammatory bowel diseases. Autoimmun Rev. 2017;16:55–63. doi: 10.1016/j.autrev.2016.09.014. [DOI] [PubMed] [Google Scholar]
- 26.Risco A., del Fresno C., Mambol A., Alsina-Beauchamp D., MacKenzie K.F., Yang H.T., Barber D.F., Morcelle C., Arthur J.S., Ley S.C., Ardavin C., Cuenda A.. p38γ and p38δ kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation. Proc Natl Acad Sci USA. 2012;109:11200–11205. doi: 10.1073/pnas.1207290109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Rodríguez E., Carasi P., Frigerio S., da Costa V., van Vliet S., Noya V., Brossard N., van Kooyk Y., García-Vallejo J.J., Freire T.. Fasciola hepatica immune regulates CD11c+ cells by interacting with the macrophage Gal/GalNAc lectin. eCollection 2017. Front Immunol. 2017;8:264. doi: 10.3389/fimmu.2017.00264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Siegmund K., Klepsch V., Hermann-Kleiter N., Baier G.. Proof of principle for a T lymphocyte intrinsic function of coronin 1A. J Biol Chem. 2016;291:22086–22092. doi: 10.1074/jbc.M116.748012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Verbanac D., Zanetti M., Romeo D.. Chemotactic and protease-inhibiting activities of antibiotic peptide precursors. FEBS Lett. 1993;317:255–258. doi: 10.1016/0014-5793(93)81287-a. [DOI] [PubMed] [Google Scholar]
- 30.Wang Y., Zhu J., Zhang L., Zhang Z., He L., Mou Y., Deng Y., Cao Y., Yang P., Su Y., Zhao J., Zhang S., Yu Q., Hu J., Chen Z., Ning Q., Xiang X., Xu Y., Wang C.Y., Xiong W.. Role of C/EBP homologous protein and endoplasmic reticulum stress in asthma exacerbation by regulating the IL-4/signal transducer and activator of transcription 6/transcription factor EC/IL-4 receptor α positive feedback loop in M2 macrophages. J Allergy Clin Immunol. 2017;140:1550–1561. doi: 10.1016/j.jaci.2017.01.024. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
